(Save Upto 75%)
Paclitero 30mg Injection contains Paclitaxel which belongs to a group of anti-cancer medicines called Taxanes.
Paclitero 30mg Injection is used to treat ovarian and breast cancer as a first line of therapy and as a second line of treatment when platinum containing medicines (such as cisplatin) or anthracyclines are insufficient to treat the disease in affected individuals
Paclitero 30mg Injection is also used to treat advanced NSCLC (non-small cell lung cancer) when surgery/radiation therapy is not suitable. The medicine is also indicated for use to treat AIDS-related Kaposi’s sarcoma when other treatments (such as anthracyclines) are insufficient to treat the disease in affected individuals
Paclitero 30mg Injection is also not recommended for use in children and adolescents (aged below 18 years). The medicine can be used with caution in elderly patients (aged above 65 years) after consulting the doctor.
Paclitero 30mg Injection is not recommended for use in patients allergic to paclitaxel and polyoxyethylated castor oil. It is also not recommended for use in patients with few white blood cells count and serious & uncontrolled infection. The medicine is also not used in patients suffering from severe liver disease.
Paclitero 30 mg Injection binds to β-tubulin subunits of microtubules, interferes with interphase (a process involving cell growth) and mitotic functions (a process of cell division), and prevents the growth of cancer cells.
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Ans :Paclitero 30mg Injection is used to treat ovarian and breast cancer as a first line of therapy and as a second line of treatment when platinum containing medicines (such as cisplatin) or anthracyclines are insufficient to treat the disease. It is also used to treat advanced NSCLC (non-small cell lung cancer) and AIDS-related Kaposi’s sarcoma in affected individuals.
Ans :Paclitero 30mg Injection works by interfering with the microtubule structures in the cell (substance which aids cancer cells to divide and multiply) thus inhibiting the growth of cancer cells and preventing its spread in affected individuals.
Ans : The most common side effects of receiving Paclitero 30mg Injection are minor allergic reactions (such as flushing, rash, itching), shortness of breath, sore throat/mouth ulcers, diarrhea, nausea, vomiting and/or loss of hair. Consult your doctor if any of these symptoms worsen
Ans :Paclitero 30mg Injection will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Ans :No, Paclitero 30mg Injection is not recommended for use in pregnant women. Women with child-bearing potential should use effective contraception method while receiving Paclitero 30mg Injection which should be continued for next-6 months after completing the treatment. Consult your doctor before receiving Paclitero 30mg Injection .
Paclitero 30mg Injection contains Paclitaxel which belongs to a group of anti-cancer medicines called Taxanes.
Paclitero 30mg Injection is used to treat ovarian and breast cancer as a first line of therapy and as a second line of treatment when platinum containing medicines (such as cisplatin) or anthracyclines are insufficient to treat the disease in affected individuals
Paclitero 30mg Injection is also used to treat advanced NSCLC (non-small cell lung cancer) when surgery/radiation therapy is not suitable. The medicine is also indicated for use to treat AIDS-related Kaposi’s sarcoma when other treatments (such as anthracyclines) are insufficient to treat the disease in affected individuals
Paclitero 30mg Injection is also not recommended for use in children and adolescents (aged below 18 years). The medicine can be used with caution in elderly patients (aged above 65 years) after consulting the doctor.
Paclitero 30mg Injection is not recommended for use in patients allergic to paclitaxel and polyoxyethylated castor oil. It is also not recommended for use in patients with few white blood cells count and serious & uncontrolled infection. The medicine is also not used in patients suffering from severe liver disease.
Paclitero 30mg Injection binds to β-tubulin subunits of microtubules, interferes with interphase (a process involving cell growth) and mitotic functions (a process of cell division), and prevents the growth of cancer cells.
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Ans :Paclitero 30mg Injection is used to treat ovarian and breast cancer as a first line of therapy and as a second line of treatment when platinum containing medicines (such as cisplatin) or anthracyclines are insufficient to treat the disease. It is also used to treat advanced NSCLC (non-small cell lung cancer) and AIDS-related Kaposi’s sarcoma in affected individuals.
Ans :Paclitero 30mg Injection works by interfering with the microtubule structures in the cell (substance which aids cancer cells to divide and multiply) thus inhibiting the growth of cancer cells and preventing its spread in affected individuals.
Ans : The most common side effects of receiving Paclitero 30mg Injection are minor allergic reactions (such as flushing, rash, itching), shortness of breath, sore throat/mouth ulcers, diarrhea, nausea, vomiting and/or loss of hair. Consult your doctor if any of these symptoms worsen
Ans :Paclitero 30mg Injection will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Ans :No, Paclitero 30mg Injection is not recommended for use in pregnant women. Women with child-bearing potential should use effective contraception method while receiving Paclitero 30mg Injection which should be continued for next-6 months after completing the treatment. Consult your doctor before receiving Paclitero 30mg Injection .